Researcher
Joost Wauters
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Regenerative medicine, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory for Clinical Infectious and Inflammatory Disorders (Division)
Responsible
From1 Oct 2023 → Today - Processing Speech and Images (PSI) (Division)
Member
From1 Aug 2020 → 30 Jun 2000 - Laboratory of Intensive Care Medicine (Division)
Member
From1 Jan 2009 → 30 Sep 2011 - Laboratory for Clinical Infectious and Inflammatory Disorders (Division)
Member
From1 Dec 2004 → Today - ESAT - PSI, Processing Speech and Images (Division)
Member
From1 Nov 1999 → 30 Jun 2000 - Department of Electrical Engineering (ESAT) (Department)
Member
From1 Oct 1999 → 31 Jan 2000
Projects
1 - 10 of 21
- From bed to bench and back in viral-associated pulmonary aspergillosis: generation of pathophysiological insight and translation into host-based biomarkersFrom1 Oct 2023 → TodayFunding: FWO fellowships
- Unraveling the pathophysiology of Virus-Associated Pulmonary Aspergillosis using zebrafishFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- A novel integrated multi-omics based approach to the management of viral-associated pulmonary aspergillosis (VAPA)From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- STRAtified Dosing based on Augmented renal clearance for CEFtriaxone in patients with severe community-acquired pneumonia: STRADA-CEF trial.From1 Oct 2022 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Unraveling the pathophysiology of Virus-Associated Pulmonary Aspergillosis: viruses and fungi combine efforts to make a perfect stormFrom19 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Mold-active Azoles: Development, Validation and Implementation of strategies for Safe and Effective Dosing (M-ADVISED)From1 Oct 2021 → TodayFunding: FWO Strategic Basic Research Grant
- Clinical validation of antifungal dosing strategies in critically ill patientsFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- The co-pathogenesis of severe influenza with invasive pulmonary aspergillosis.From1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- Dual-band fibered confocal fluorescence microscope for the intravital interrogation of deep tissues and organs in real time and with cellular resolutionFrom1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- Development and streamlining a validation and implementation workflow for model-informed precision dosing for biologicals and antimicrobialsFrom1 Oct 2020 → 30 Sep 2022Funding: IOF - technology validation in lab
Publications
41 - 50 of 137
- A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)(2021)
Authors: Simon Feys, Katrien Lagrou, Joost Wauters
- Interaction between flucloxacillin and azoles: Is isavuconazole next?(2021)
Authors: Ruth Van Daele, Joost Wauters, Christophe Vandenbriele, Katrien Lagrou, Robin Vos, Yves Debaveye
Pages: 1508 - 1511 - Influenza-Associated Pulmonary Aspergillosis: Seek, and You Shall Find!(2021)
Authors: Simon Feys, Joost Wauters
Pages: E1265 - E1266 - Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients(2021)
Authors: Katrien Lagrou, Joost Wauters
- Article Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb(2021)
Authors: Marnick Clijsters, Wout Backaert, Arno Vanstapel, Lukas Marcelis, Hai Zhou, Yves Debaveye, Paul De Munter, Jan Gunst, Mark Jorissen, Katrien Lagrou, et al.
Pages: 5932 - + - Aerobic exercise capacity in long-term survivors of critical illness: secondary analysis of the post-EPaNIC follow-up study(2021)
Authors: Nathalie Van Aerde, Yves Debaveye, Alexander Wilmer, Michael Casaer, Jan Gunst, Joost Wauters, Kaatje Goetschalckx, Rik Gosselink, Greet Van den Berghe, Greet Hermans
Pages: 1462 - 1471 - Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis1(2021)
Authors: Lore Vanderbeke, Katrien Lagrou, Simon Feys, Joost Wauters
Pages: 2892 - 2898 - Critical influenza and prophylactic antifungal therapy for aspergillosis: a nuanced approach to a pertinent infectious disease(2021)
Authors: Lore Vanderbeke, Katrien Lagrou, Joost Wauters
Pages: 1343 - 1344 - Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host(2021)
Authors: Veronica Llorens-Rico Llorens-Rico, Johan Van Weyenbergh, Sander Jansen, Junbin Qian, Soraya Menezes, Pierre Van Mol, Lore Vanderbeke, Christophe Dooms, Jan Gunst, Greet Hermans, et al.
- Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model(2021)
Authors: Laura Seldeslachts, Lore Vanderbeke, Agustin Reséndiz Sharpe, Tessa Ostyn, Lieve Naesens, Stephanie Humblet-Baron, Erik Verbeken, Katrien Lagrou, Joost Wauters, Greetje Vande Velde
Pages: 2493 - 2508